H.R. 3697 · 110th Congress
Strategies to Address Antimicrobial Resistance Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MathesonSponsor28 cosponsors · 21 D, 7 R
D
Baldwin
MF
R
Ferguson
HW
D
Waxman
BB
D
Baird
EE
D
Engel
PK
D
Kanjorski
JO
D
Oberstar
JC
D
Cooper
VF
R
Fossella
BF
D
Filner
RF
R
Frelinghuysen
ET
D
Towns
AW
D
Weiner
GG
D
Green
BM
D
McCollum
ZW
R
Wamp
JM
D
Moran
LC
D
Capps
BC
R
Cubin
RH
D
Hinojosa
RW
D
Wexler
HC
D
Cuellar
BH
D
Hill
TM
R
Murphy
AC
D
Carson
SL
D
Lynch
MB
D
Bordallo
TM
R
McCotter3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance in the Office of the Assistant Secretary for Health to develop plans for addressing antimicrobial resistance in the United States…
What it does: CRS summary · Introduced in House · Sep 27, 2007
Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance in the Office of the Assistant Secretary for Health to develop plans for addressing antimicrobial resistance in the United States and internationally; (2) establish the Public Health Antimicrobial Advisory Board to assist the Director; and (3) develop an antimicrobial resistance strategic research plan. Renews the Antimicrobial Resistance Task Force and sets forth its membership and duties.
Requires sponsors of human and animal antimicrobial drug products to report to the Office of Antimicrobial Resistance the amount of such drug products sold or distributed in the United States in a calendar year. Requires the Director to make summaries of drug distribution data publicly available.
Requires the Secretary to: (1) establish at least 10 Antimicrobial Resistance Clinical Research and Public Health Network sites to describe outbreaks of antimicrobial resistant pathogens and monitor the patterns of such pathogens in individuals; and (2) award competitive grants to establish demonstration projects to assess the scope of the antimicrobial resistance problem and the use of antimicrobial drugs.
Requires the Comptroller General to report to Congress on the effectiveness of this Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Strategies to Address Antimicrobial Resistance Act
Latest action (Nov 8, 2007): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Sep 27, 2007
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.